Ozodbekova, U. (2026). GLP-1-Based Therapies in Type 2 Diabetes and Obesity: Current Evidence, Cardiorenal Benefits, Safety and Future Directions. Bulletin of Contemporary Researches, 2(4), 118-123. https://bulconre.com/index.php/mult/article/view/54